Property Perspectives

CrowdStreet’s Life Science Roundtable

CrowdStreet's Thomas McDonald sat down with Jay Doherty and Jay Hirsh to discuss the growth of the life science market and what to expect in the future.

by Cyrus Maunakea
In our latest Life Sciences roundtable, CrowdStreet’s Investment Product & Portfolio Manager Thomas McDonald hosted a discussion with Cabot, Cabot, and Forbes CEO Jay Doherty and Jumbo Capital Management Co-founder and Managing Partner Jay Hirsh. The group discussed the growth of the life sciences market and what investors can expect in the future. Some highlights from the roundtable included:
  • The latest news of a huge player in the CRE market acquiring a massive portfolio of life science space 
  • The types of companies driving demand for life science-related properties
  • Where to find the top life science hubs in the U.S. 
  • The unique requirements of tenants in this space and how that impacts development
  • How some firms are repositioning existing properties to produce more supply in the most desired and constrained markets
  • How sectors like pharmaceuticals, scientific research, and robotics continue to drive this industry forward.
Group 2010204
Get the word on the street.

Sign up now for our newsletter to discover key insights, market analysis updates, and expert opinions.

You're In!

Thanks for signing up for our monthly newsletter.